AbbVie spends $100B on R and D, buys Regeneron for $5.6B to bolster pipeline amidst US pharma pricing shifts

martes, 13 de enero de 2026, 7:52 am ETnull min de lectura
author avatar
BullRush

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios